Nuvalent to Present at the 2022 Jefferies Healthcare Conference

Rhea-AI Summary

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical firm, will present at the 2022 Jefferies Healthcare Conference on June 9, 2022, at 1:00 p.m. ET, in New York City. CEO James Porter, Ph.D., will lead the presentation, aiming to highlight the company's advances in creating targeted therapies for cancer. A live webcast of the presentation will be accessible via the company's website, with an archived version available for 30 days. Nuvalent focuses on innovative small molecules to tackle challenges in kinase-targeted therapies.

CAMBRIDGE, Mass., June 2, 2022 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference on Thursday, June 9, 2022, at 1:00 p.m. ET in New York City.

A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentation.

About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive non-small cell lung cancer (NSCLC), along with multiple discovery-stage research programs. We routinely post information that may be important to investors on our website at www.nuvalent.com. Follow us on Twitter (@nuvalent) and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-present-at-the-2022-jefferies-healthcare-conference-301559988.html

SOURCE Nuvalent, Inc.

FAQ

When will Nuvalent present at the 2022 Jefferies Healthcare Conference?

Nuvalent will present on June 9, 2022, at 1:00 p.m. ET.

Who is presenting at the Jefferies Healthcare Conference for Nuvalent?

CEO James Porter, Ph.D., will represent Nuvalent at the conference.

Where is the 2022 Jefferies Healthcare Conference being held?

The conference is being held in New York City.

How can I watch the Nuvalent presentation at the conference?

The presentation will be available via a live webcast on Nuvalent's website.

What is the focus of Nuvalent's research?

Nuvalent specializes in creating targeted therapies for cancer, particularly for kinase targets.